207 related articles for article (PubMed ID: 35752221)
1. Oncostatic activities of melatonin: Roles in cell cycle, apoptosis, and autophagy.
Targhazeh N; Reiter RJ; Rahimi M; Qujeq D; Yousefi T; Shahavi MH; Mir SM
Biochimie; 2022 Nov; 202():34-48. PubMed ID: 35752221
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic actions of melatonin in cancer: possible mechanisms.
Srinivasan V; Spence DW; Pandi-Perumal SR; Trakht I; Cardinali DP
Integr Cancer Ther; 2008 Sep; 7(3):189-203. PubMed ID: 18815150
[TBL] [Abstract][Full Text] [Related]
3. Basic mechanisms involved in the anti-cancer effects of melatonin.
Mediavilla MD; Sanchez-Barcelo EJ; Tan DX; Manchester L; Reiter RJ
Curr Med Chem; 2010; 17(36):4462-81. PubMed ID: 21062257
[TBL] [Abstract][Full Text] [Related]
4. Melatonin: an endogenous miraculous indolamine, fights against cancer progression.
Samanta S
J Cancer Res Clin Oncol; 2020 Aug; 146(8):1893-1922. PubMed ID: 32583237
[TBL] [Abstract][Full Text] [Related]
5. Action of melatonin on squamous cell carcinoma and other tumors of the oral cavity (Review).
Cutando A; López-Valverde A; DE Vicente J; Gimenez JL; Carcía IA; DE Diego RG
Oncol Lett; 2014 Apr; 7(4):923-926. PubMed ID: 24944644
[TBL] [Abstract][Full Text] [Related]
6. Oncostatic activities of melatonin: Roles in cell cycle, apoptosis, and autophagy [Biochimie 200 (2022) 44-59].
Targhazeh N; Reiter RJ; Rahimi M; Qujeq D; Yousefi T; Shahavi MH; Mir SM
Biochimie; 2022 Sep; 200():44-59. PubMed ID: 35618158
[No Abstract] [Full Text] [Related]
7. Effect and mechanism of melatonin's action on the proliferation of human umbilical vein endothelial cells.
Cui P; Luo Z; Zhang H; Su Y; Li A; Li H; Zhang J; Yang Z; Xiu R
J Pineal Res; 2006 Nov; 41(4):358-62. PubMed ID: 17014693
[TBL] [Abstract][Full Text] [Related]
8. The validity of melatonin as an oncostatic agent.
Panzer A; Viljoen M
J Pineal Res; 1997 May; 22(4):184-202. PubMed ID: 9247204
[TBL] [Abstract][Full Text] [Related]
9. Oncostatic action of melatonin: facts and question marks.
Pawlikowski M; Winczyk K; Karasek M
Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():24-9. PubMed ID: 12019348
[TBL] [Abstract][Full Text] [Related]
10. Melatonin: Nature's most versatile biological signal?
Pandi-Perumal SR; Srinivasan V; Maestroni GJ; Cardinali DP; Poeggeler B; Hardeland R
FEBS J; 2006 Jul; 273(13):2813-38. PubMed ID: 16817850
[TBL] [Abstract][Full Text] [Related]
11. Pain control by melatonin: Physiological and pharmacological effects.
Chen WW; Zhang X; Huang WJ
Exp Ther Med; 2016 Oct; 12(4):1963-1968. PubMed ID: 27698681
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of breast cancer cell invasion by melatonin is mediated through regulation of the p38 mitogen-activated protein kinase signaling pathway.
Mao L; Yuan L; Slakey LM; Jones FE; Burow ME; Hill SM
Breast Cancer Res; 2010; 12(6):R107. PubMed ID: 21167057
[TBL] [Abstract][Full Text] [Related]
13. Melatonin and mammary cancer: a short review.
Sánchez-Barceló EJ; Cos S; Fernández R; Mediavilla MD
Endocr Relat Cancer; 2003 Jun; 10(2):153-9. PubMed ID: 12790777
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional activation of the nuclear receptor RZR alpha by the pineal gland hormone melatonin and identification of CGP 52608 as a synthetic ligand.
Wiesenberg I; Missbach M; Kahlen JP; Schräder M; Carlberg C
Nucleic Acids Res; 1995 Feb; 23(3):327-33. PubMed ID: 7885826
[TBL] [Abstract][Full Text] [Related]
15. Melatonin as a chronobiotic/anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy.
Blask DE; Sauer LA; Dauchy RT
Curr Top Med Chem; 2002 Feb; 2(2):113-32. PubMed ID: 11899096
[TBL] [Abstract][Full Text] [Related]
16. The Potential Oncostatic Effects of Melatonin against Prostate Cancer.
Samanta S
Crit Rev Oncog; 2021; 26(3):53-67. PubMed ID: 35377986
[TBL] [Abstract][Full Text] [Related]
17. Growth-inhibitory activity of melatonin on human androgen-independent DU 145 prostate cancer cells.
Marelli MM; Limonta P; Maggi R; Motta M; Moretti RM
Prostate; 2000 Nov; 45(3):238-44. PubMed ID: 11074526
[TBL] [Abstract][Full Text] [Related]
18. Melatonin membrane receptors in peripheral tissues: distribution and functions.
Slominski RM; Reiter RJ; Schlabritz-Loutsevitch N; Ostrom RS; Slominski AT
Mol Cell Endocrinol; 2012 Apr; 351(2):152-66. PubMed ID: 22245784
[TBL] [Abstract][Full Text] [Related]
19. The orphan receptor family RZR/ROR, melatonin and 5-lipoxygenase: an unexpected relationship.
Carlberg C; Wiesenberg I
J Pineal Res; 1995 May; 18(4):171-8. PubMed ID: 8531047
[TBL] [Abstract][Full Text] [Related]
20. Melatonin and its ubiquitous anticancer effects.
Bhattacharya S; Patel KK; Dehari D; Agrawal AK; Singh S
Mol Cell Biochem; 2019 Dec; 462(1-2):133-155. PubMed ID: 31451998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
